$ Value
$0
Shares
99,500
Price
$0
Filed
Apr 16
Insider
Name
Walker Robert Edward
Title
EVP, R&D
CIK
0002127840
Roles
Transaction Details
Transaction Date
2026-04-14
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
99,500
Footnotes
Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. | Each RSU represents a contingent right to receive one share of the "Company" common stock. | The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the April 14, 2026 grant date, in each case subject to continued employment with the Company through such vesting date.
Filing Info
Other Insiders at NVAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Jacobs John C
President and CEO
|
— | — | 2026-01-23 |
|
Walker Robert Edward
EVP, R&D
|
— | — | 2026-04-14 |